FBLN5 and neoplasm: Even more, Kaplan-Meier survival curves of progression-free survival (PFS) demonstrated inferior survival probabilities in patients with high tumor expression of PXDNL (p=0.0001) and SDC1 (p<0.0001) and low tumor expression of FBLN1 (p=0.0087), FBLN5 (p=0.026) and ADAMTS8 (p<0.0001) (Figure S2C).